Forecaster

Forecaster

The RXA Forecaster tool produces forecasts of the predicted sales of pharmaceutical companies’ product portfolios, based on historic prescribing trends.

With the RXA Forecaster you can plan for the future, set sales targets and keep track of sales activity at territory and CCG levels.

With the RXA Forecaster tool you can:

  • Employ methodologies, including the Holt-Winters seasonal method
  • Include user-defined parameters – E.g. expected level of product switch, underlying market growth etc.
  • Produce actual vs. forecast comparisons to help assess forecast accuracy
We make analytics simple
Request your demonstration today

“The budget impact models are a real benefit.”

National Sales Manager, UK Pharmaceutical Company

“I use the data from RXA Budget Impact Model daily. It is the core of everything we do! I cannot recommend the model more. It has had a substantial impact on our business across the board and I would not be without it.”

Country Manager UK, Leading Diagnostics Company

“Rx Analyser is already having a significant impact on our business, allowing our Territory Managers to focus on established CCG accounts and identify practice level successes and others for further development.”

Managing Director, UK Diabetes Healthcare Company

“My favourite feature? The market share data – and territory growth or decline. The RXA tool really allows a company to fine tune their sales strategies and focus on the more profitable accounts. It allows you to target accounts for quick wins and get a good picture of what your competitor’s focuses and successes are.”

National Sales Manager, UK Pharmaceutical Company

“RX Analyser is an extremely intuitive tool with numerous beneficial features.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“At a CCG level we can show our customers how we can work with individual surgeries to get substantial cost savings and utilize their budgets better. We work with medicines management teams to help them to save money whilst also improving outcomes.”

Country Manager UK, Leading Diagnostics Company

Sign up for added insights